Literature DB >> 25920683

Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.

Chantana Polprasert1, Isabell Schulze2, Mikkael A Sekeres3, Hideki Makishima4, Bartlomiej Przychodzen4, Naoko Hosono5, Jarnail Singh6, Richard A Padgett6, Xiaorong Gu4, James G Phillips4, Michael Clemente4, Yvonne Parker4, Daniel Lindner4, Brittney Dienes4, Eckhard Jankowsky7, Yogen Saunthararajah4, Yang Du8, Kevin Oakley8, Nhu Nguyen8, Sudipto Mukherjee9, Caroline Pabst10, Lucy A Godley11, Jane E Churpek11, Daniel A Pollyea12, Utz Krug13, Wolfgang E Berdel13, Hans-Ulrich Klein14, Martin Dugas14, Yuichi Shiraishi15, Kenichi Chiba15, Hiroko Tanaka15, Satoru Miyano15, Kenichi Yoshida16, Seishi Ogawa16, Carsten Müller-Tidow17, Jaroslaw P Maciejewski18.   

Abstract

Most cases of adult myeloid neoplasms are routinely assumed to be sporadic. Here, we describe an adult familial acute myeloid leukemia (AML) syndrome caused by germline mutations in the DEAD/H-box helicase gene DDX41. DDX41 was also found to be affected by somatic mutations in sporadic cases of myeloid neoplasms as well as in a biallelic fashion in 50% of patients with germline DDX41 mutations. Moreover, corresponding deletions on 5q35.3 present in 6% of cases led to haploinsufficient DDX41 expression. DDX41 lesions caused altered pre-mRNA splicing and RNA processing. DDX41 is exemplary of other RNA helicase genes also affected by somatic mutations, suggesting that they constitute a family of tumor suppressor genes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25920683      PMCID: PMC8713504          DOI: 10.1016/j.ccell.2015.03.017

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  40 in total

Review 1.  Defects in spliceosomal machinery: a new pathway of leukaemogenesis.

Authors:  Jaroslaw P Maciejewski; Richard A Padgett
Journal:  Br J Haematol       Date:  2012-05-18       Impact factor: 6.998

Review 2.  Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.

Authors:  Jaroslaw P Maciejewski; Ramon V Tiu; Christine O'Keefe
Journal:  Br J Haematol       Date:  2009-06-26       Impact factor: 6.998

3.  Differential expression in RNA-seq: a matter of depth.

Authors:  Sonia Tarazona; Fernando García-Alcalde; Joaquín Dopazo; Alberto Ferrer; Ana Conesa
Journal:  Genome Res       Date:  2011-09-08       Impact factor: 9.043

Review 4.  DEAD-box helicases as integrators of RNA, nucleotide and protein binding.

Authors:  Andrea A Putnam; Eckhard Jankowsky
Journal:  Biochim Biophys Acta       Date:  2013-02-15

5.  KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia.

Authors:  Jin He; Anh Tram Nguyen; Yi Zhang
Journal:  Blood       Date:  2011-02-10       Impact factor: 22.113

6.  Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.

Authors:  Marcus Bantscheff; Carsten Hopf; Mikhail M Savitski; Antje Dittmann; Paola Grandi; Anne-Marie Michon; Judith Schlegl; Yann Abraham; Isabelle Becher; Giovanna Bergamini; Markus Boesche; Manja Delling; Birgit Dümpelfeld; Dirk Eberhard; Carola Huthmacher; Toby Mathieson; Daniel Poeckel; Valérie Reader; Katja Strunk; Gavain Sweetman; Ulrich Kruse; Gitte Neubauer; Nigel G Ramsden; Gerard Drewes
Journal:  Nat Biotechnol       Date:  2011-01-23       Impact factor: 54.908

7.  A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.

Authors:  Outi Kilpivaara; Semanti Mukherjee; Alison M Schram; Martha Wadleigh; Ann Mullally; Benjamin L Ebert; Adam Bass; Sachie Marubayashi; Adriana Heguy; Guillermo Garcia-Manero; Hagop Kantarjian; Kenneth Offit; Richard M Stone; D Gary Gilliland; Robert J Klein; Ross L Levine
Journal:  Nat Genet       Date:  2009-03-15       Impact factor: 38.330

8.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

9.  ZNF198 stabilizes the LSD1-CoREST-HDAC1 complex on chromatin through its MYM-type zinc fingers.

Authors:  Christian B Gocke; Hongtao Yu
Journal:  PLoS One       Date:  2008-09-22       Impact factor: 3.240

10.  Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.

Authors:  Petter S Woll; Una Kjällquist; Onima Chowdhury; Helen Doolittle; David C Wedge; Supat Thongjuea; Rikard Erlandsson; Mtakai Ngara; Kristina Anderson; Qiaolin Deng; Adam J Mead; Laura Stenson; Alice Giustacchini; Sara Duarte; Eleni Giannoulatou; Stephen Taylor; Mohsen Karimi; Christian Scharenberg; Teresa Mortera-Blanco; Iain C Macaulay; Sally-Ann Clark; Ingunn Dybedal; Dag Josefsen; Pierre Fenaux; Peter Hokland; Mette S Holm; Mario Cazzola; Luca Malcovati; Sudhir Tauro; David Bowen; Jacqueline Boultwood; Andrea Pellagatti; John E Pimanda; Ashwin Unnikrishnan; Paresh Vyas; Gudrun Göhring; Brigitte Schlegelberger; Magnus Tobiasson; Gunnar Kvalheim; Stefan N Constantinescu; Claus Nerlov; Lars Nilsson; Peter J Campbell; Rickard Sandberg; Elli Papaemmanuil; Eva Hellström-Lindberg; Sten Linnarsson; Sten Eirik W Jacobsen
Journal:  Cancer Cell       Date:  2014-05-15       Impact factor: 31.743

View more
  125 in total

1.  Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.

Authors:  I Antony-Debré; N Duployez; M Bucci; S Geffroy; J-B Micol; A Renneville; N Boissel; N Dhédin; D Réa; B Nelken; C Berthon; T Leblanc; M-J Mozziconacci; R Favier; P G Heller; O Abdel-Wahab; H Raslova; V Latger-Cannard; C Preudhomme
Journal:  Leukemia       Date:  2015-08-28       Impact factor: 11.528

2.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

3.  Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation.

Authors:  P Hirsch; A C Mamez; R Belhocine; S Lapusan; R Tang; L Suner; D Bories; C Marzac; F Fava; O Legrand; M Mohty; L Douay; F Delhommeau
Journal:  Leukemia       Date:  2016-03-01       Impact factor: 11.528

Review 4.  DDX41-related myeloid neoplasia.

Authors:  Jaroslaw P Maciejewski; Richard A Padgett; Anna L Brown; Carsten Müller-Tidow
Journal:  Semin Hematol       Date:  2017-04-21       Impact factor: 3.851

Review 5.  The Emerging Role of Hematopathologists and Molecular Pathologists in Detection, Monitoring, and Management of Myeloid Neoplasms with Germline Predisposition.

Authors:  Rashmi Kanagal-Shamanna
Journal:  Curr Hematol Malig Rep       Date:  2021-05-24       Impact factor: 3.952

6.  Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia.

Authors:  Filippo Pinto E Vairo; Alejandro Ferrer; Elizabeth Cathcart-Rake; Rebecca L King; Matthew T Howard; David S Viswanatha; Eric W Klee; Abhishek A Mangaonkar; Mrinal M Patnaik
Journal:  Leuk Lymphoma       Date:  2018-11-08

7.  Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation.

Authors:  S Kobayashi; A Kobayashi; Y Osawa; S Nagao; K Takano; Y Okada; N Tachi; M Teramoto; T Kawamura; T Horiuchi; S Kato; T Maekawa; T Yamamura; J Watanabe; Y Harada; H Harada; K Sato; F Kimura
Journal:  Leukemia       Date:  2017-02-14       Impact factor: 11.528

Review 8.  Familial predisposition of myeloid malignancies: biological and clinical significance of recurrent germ line mutations.

Authors:  Hirotaka Matsui
Journal:  Int J Hematol       Date:  2017-06-19       Impact factor: 2.490

9.  Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation.

Authors:  G Berger; E van den Berg; B Sikkema-Raddatz; K M Abbott; R J Sinke; L B Bungener; A B Mulder; E Vellenga
Journal:  Leukemia       Date:  2016-10-31       Impact factor: 11.528

Review 10.  Mechanisms of Immune Tolerance in Leukemia and Lymphoma.

Authors:  Emily K Curran; James Godfrey; Justin Kline
Journal:  Trends Immunol       Date:  2017-05-13       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.